Skip to main content
TipRanks
Go Ultimate75% OFF

NurExone Biologic (NRX) Cash flow

13 Followers

NurExone Biologic Cash Flow

TSE:NRX's free cash flow for Q2 2026 was $-990.00K. For the 2026 fiscal year, TSE:NRX's free cash flow was decreased by $-34.00K and operating cash flow was $-956.00K. See a summary of the company’s cash flow.

Cash Flow
Cash FlowMar 26Mar 25Mar 24Dec 22Mar 22
$ -4.51M$ -4.89M$ -2.94M$ -3.85M$ -1.21M
$ -55.00K$ -658.00K$ -97.00K$ -89.00K$ 0.00
$ 5.83M$ 5.88M$ 1.13M$ 4.29M$ 3.40M
$ 2.14M$ 700.00K$ 541.00K$ 2.46M$ 2.21M
$ -4.57M$ -5.54M$ -3.06M$ -3.90M$ -1.21M

Currency in USD

NurExone Biologic Cash Flow

-7.5M-5M-2.5M02.5M5M7.5M20212022202320242025OperatingInvestingFinancing